Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.3.1.39 extracted from

  • Sinha, I.; Dick, T.
    Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCG (2004), J. Antimicrob. Chemother., 53, 1072-1075.
    View publication on PubMed

Application

Application Comment Organism
medicine enzyme is a potential target for antimycobacterial compounds Mycobacterium tuberculosis variant bovis

Protein Variants

Protein Variants Comment Organism
additional information enzyme overexpression in strain BCG confers resistance to trifluoroperazine, but not to isoniazid Mycobacterium tuberculosis variant bovis

Inhibitors

Inhibitors Comment Organism Structure
isoniazid acts synergistically with trifluoroperazine Mycobacterium tuberculosis variant bovis
trifluoroperazine acts as calmodulin-antagonist in animals, inhibits mycobacterial lipid synthesis, acts synergistically with isoniazid Mycobacterium tuberculosis variant bovis

Organism

Organism UniProt Comment Textmining
Mycobacterium tuberculosis variant bovis
-
Karlson and Lessel, ATCC 35734
-

Source Tissue

Source Tissue Comment Organism Textmining

Synonyms

Synonyms Comment Organism
malonyl coenzyme A:acyl carrier protein transacylase
-
Mycobacterium tuberculosis variant bovis
MCAT
-
Mycobacterium tuberculosis variant bovis